ALUNG TECHNOLOGIES INC

Profile

Company Names

ALUNG TECHNOLOGIES INC

Addresses

2500 JANE STREET, SUITE 1, PITTSBURGH, PA 15203

333 EAST CARSON STREET, SUITE 517A, PITTSBURGH, PA 15219

Phone Numbers

412-697-3370

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

PENNSYLVANIA

Total Amount Raised:

$133,151,206.00

Number of Funding Rounds:

15
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
15
2021-05-06 
$4,589,862.00 
$12,000,000.00 
$7,410,138.00 
Debt 
14
2020-10-30 
$5,441,577.00 
$15,000,000.00 
$9,558,423.00 
Debt 
13
2020-05-20 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
12
2020-02-10 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
11
2020-01-15 
$3,262,900.00 
$5,000,000.00 
$1,737,100.00 
Debt 
10
2019-08-02 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
9
2018-12-28 
$4,999,990.00 
$5,000,000.00 
$10.00 
Debt 
8
2017-03-31 
$37,544,283.00 
$42,646,843.00 
$5,102,560.00 
Equity 
7
2016-12-27 
$2,602,233.00 
$4,000,000.00 
$1,397,767.00 
Debt 
6
2015-04-30 
$12,000,000.00 
$12,000,000.00 
$0.00 
Debt 
5
2014-03-31 
$10,843,753.00 
$11,150,722.00 
$306,969.00 
Equity 
4
2013-03-28 
$15,785,268.00 
$17,000,000.00 
$1,214,732.00 
Equity 
3
2011-11-11 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
2
2010-02-09 
$13,500,000.00 
$13,500,000.00 
$0.00 
Equity 
1
2009-09-25 
$2,581,340.00 
$2,581,340.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOUIS 
 
CHOY 
DIRECTOR
NICHOLAS 
 
CULLEN 
DIRECTOR
NICHOLAS 
E. 
CULLEN 
DIRECTOR
JEANNE 
J. 
CUNICELLI 
DIRECTOR
JEANNE 
 
CUNNICELLI 
DIRECTOR
PETER 
DECOMO 
EXECUTIVE OFFICER, DIRECTOR
PETER 
M. 
DECOMO 
EXECUTIVE OFFICER, DIRECTOR
GARY 
 
GLAUSSER 
DIRECTOR
GARY 
G. 
GLAUSSER 
DIRECTOR
GARY 
J. 
GLAUSSER 
DIRECTOR
DAVID 
HAFFNER 
EXECUTIVE OFFICER
DAVID 
J. 
HAFFNER 
EXECUTIVE OFFICER, DIRECTOR
NICHOLAS 
KUHN 
EXECUTIVE OFFICER, DIRECTOR
NICHOLAS 
J. 
KUHN 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
KUZMISHIN 
DIRECTOR
KRAIG 
J. 
MCEWEN 
DIRECTOR
GERALD 
MCGINNIS 
DIRECTOR
GERALD 
E. 
MCGINNIS 
DIRECTOR
JOHN 
 
MCILLWRAITH 
DIRECTOR
JOHN 
E. 
MCILWRAITH 
DIRECTOR
DAVID 
L. 
MOTLEY 
DIRECTOR
DAVID 
M. 
MOTLEY 
DIRECTOR
WILLIAM 
ROSS 
DIRECTOR
WILLIAM 
B. 
ROSS 
DIRECTOR
ADAM 
 
SEIVER 
DIRECTOR
ADAM 
G. 
SEIVER 
DIRECTOR
JOSEPH 
STEVENS 
DIRECTOR
JOSEPH 
STEVENS III 
DIRECTOR
JOSEPH 
J. 
STEVENS III 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-05-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-05-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-10-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-08-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-12-28 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-27 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-30 
D/A
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Debt 
2015-04-30 
D
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Debt 
2015-04-30 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-03-31 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-03-31 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-03-31 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-03-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-03-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-03-28 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-03-28 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-11-11 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-11-11 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-11-11 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-02-09 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-02-09 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-02-09 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-09-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
WEILD + CO.
WEILD + CO.
KEE COLEN
RAYMOND JAMES + ASSOCIATES, INC.
705
KEE COLEN
RAYMOND JAMES + ASSOCIATES, INC.
705
EQUINOX SECURITIES, INC.
MELVIN PIRCHESKY
NONE
NONE
MELVIN PIRCHESKY
MELVIN PIRCHESKY
TRUSTMONT FINANCIAL GROUP, INC.